NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sensydia

Sensydia

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.sensydia.com/

Last Round

Grant

Jun 9, 2025

Total Funding Raised

$7.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Sensydia is a healthcare technology company that develops a portable, point-of-care hemodynamic measurement device for the treatment and management of heart disease patients, facilitating non-invasive monitoring of critical cardiac metrics to enhance patient outcomes and reduce healthcare costs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

hemodynamic monitoringcardiac assessmentmedical AIpoint-of-care diagnosticsnon-invasive monitoringdigital healthacoustic biosensorscardiology deviceheart failure monitoringhealth IoTmedtechremote patient monitoringRPMclinical decision supportwearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sensydia Comparables

Compare Sensydia with similar companies based on industry and business-model similarity.

Sensydia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acorai
88%
Respirix, Inc.
82%
NI Medical
80%

Sensydia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 9, 2025
GrantJun 5, 2023
VC RoundMay 9, 2023
Series BJan 19, 2022
VC RoundJul 23, 2020
Series B
Jul 18, 2017

Key People

Founding team and executive leadership

Aman Mahajan

Founder And Chief Medical Officer

Founding Team

Anthony Arnold

President Chief Executive Officer

Executive Team

Tom Bruggere

Co-Founder, Former CEO

Founding Team

Rusty Page

President COO

Executive Team

Sensydia Investors

Notable investors and investment history

Sensydia investors
InvestorRounds
NIH RADxGrant
Colle CapitalVC Round, Series B
Orlando Health VenturesVC Round
National Heart, Lung, and Blood InstituteGrant
Frontier Venture CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 41% MoM.

  • Apr 19, 2026

    Monthly visitors grew 43% MoM, reaching 3.4K.

Sensydia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sensydia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sensydia's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range14
Year Founded2015
Last FundingJun 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.